These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Elicited hippocampal theta rhythm: a screen for anxiolytic and procognitive drugs through changes in hippocampal function? McNaughton N; Kocsis B; Hajós M Behav Pharmacol; 2007 Sep; 18(5-6):329-46. PubMed ID: 17762505 [TBL] [Abstract][Full Text] [Related]
4. Preclinical research into cognition enhancers. Sarter M Trends Pharmacol Sci; 2006 Nov; 27(11):602-8. PubMed ID: 16997388 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship studies of theophylline analogs on population responses in the rat hippocampus in vitro. Ananthalakshmi KV; Bartl T; Aziza MH; Novotný L; Marek R; Benes L; Kombian SB Bioorg Med Chem; 2008 Sep; 16(17):8142-50. PubMed ID: 18676148 [TBL] [Abstract][Full Text] [Related]
6. Cognitive enhancement: promises and perils. Hyman SE Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872 [TBL] [Abstract][Full Text] [Related]
10. Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers. Costa V; Lugert S; Jagasia R Handb Exp Pharmacol; 2015; 228():99-155. PubMed ID: 25977081 [TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated fatty acids as putative cognitive enhancers. Yehuda S Med Hypotheses; 2012 Oct; 79(4):456-61. PubMed ID: 22800804 [TBL] [Abstract][Full Text] [Related]
12. The changing face of insulin receptors. Darlington CL Curr Opin Investig Drugs; 2007 Nov; 8(11):885-6. PubMed ID: 17979021 [No Abstract] [Full Text] [Related]
13. Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Takeda S; Sato N; Niisato K; Takeuchi D; Kurinami H; Shinohara M; Rakugi H; Kano M; Morishita R Brain Res; 2009 Jul; 1280():137-47. PubMed ID: 19464276 [TBL] [Abstract][Full Text] [Related]
14. Cognitive enhancers (nootropics). Part 1: drugs interacting with receptors. Froestl W; Muhs A; Pfeifer A J Alzheimers Dis; 2012; 32(4):793-887. PubMed ID: 22886028 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717. Hampson RE; España RA; Rogers GA; Porrino LJ; Deadwyler SA Psychopharmacology (Berl); 2009 Jan; 202(1-3):355-69. PubMed ID: 18985324 [TBL] [Abstract][Full Text] [Related]
16. Cognitive enhancers for the treatment of neuropsychiatric disorders: clinical and preclinical investigations. Kantak KM; Hofmann SG Pharmacol Biochem Behav; 2011 Aug; 99(2):113-5. PubMed ID: 21316387 [No Abstract] [Full Text] [Related]
17. A new treatment for hypoxic brain injury? Flood P Anesth Analg; 2007 Sep; 105(3):559-60. PubMed ID: 17717206 [No Abstract] [Full Text] [Related]